Please login to the form below

Not currently logged in
Email:
Password:

Cardio3 BioSciences

This page shows the latest Cardio3 BioSciences news and features for those working in and with pharma, biotech and healthcare.

The development of stem cell therapies

The development of stem cell therapies

Cardio3 BioSciences is developing C-Cure, a human adult bone marrow derived somatic cell therapy.

Latest news

More from news
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest Intelligence

  • Pharma deals during January 2015 Pharma deals during January 2015

    In the same field but an asset acquisition, Cardio3 BioSciences bought the oncology division of Celdara Medical for a headline of $180m in a mix of cash, stock and royalties.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest appointments

More from appointments
Approximately 1 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Porterhouse Medical Group

The Porterhouse Medical Group provides market research, insights, and scientific and medical communication services to the pharmaceutical industry across the...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics